Intech Investment Management LLC Boosts Stock Position in Option Care Health, Inc. $OPCH

Intech Investment Management LLC lifted its position in Option Care Health, Inc. (NASDAQ:OPCH) by 13.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 213,527 shares of the company’s stock after purchasing an additional 25,360 shares during the quarter. Intech Investment Management LLC’s holdings in Option Care Health were worth $6,803,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. V Square Quantitative Management LLC purchased a new position in shares of Option Care Health in the 4th quarter worth about $25,000. Cornerstone Planning Group LLC boosted its holdings in shares of Option Care Health by 7,621.4% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after purchasing an additional 1,067 shares in the last quarter. Advisory Services Network LLC purchased a new position in shares of Option Care Health in the 3rd quarter worth about $35,000. McIlrath & Eck LLC purchased a new position in shares of Option Care Health in the 2nd quarter worth about $37,000. Finally, Caitong International Asset Management Co. Ltd purchased a new position in shares of Option Care Health in the 3rd quarter worth about $38,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Option Care Health

In other Option Care Health news, CEO John Charles Rademacher purchased 12,500 shares of the stock in a transaction on Monday, May 4th. The stock was acquired at an average price of $21.18 per share, with a total value of $264,750.00. Following the transaction, the chief executive officer directly owned 695,152 shares of the company’s stock, valued at approximately $14,723,319.36. This trade represents a 1.83% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy P. Sullivan acquired 24,154 shares of the company’s stock in a transaction on Thursday, May 7th. The stock was acquired at an average price of $20.69 per share, with a total value of $499,746.26. Following the acquisition, the director owned 73,383 shares in the company, valued at approximately $1,518,294.27. This trade represents a 49.06% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased 73,264 shares of company stock worth $1,548,316 in the last ninety days. 1.70% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on OPCH. Weiss Ratings cut Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Wall Street Zen cut Option Care Health from a “buy” rating to a “hold” rating in a report on Saturday, February 28th. TD Cowen cut their price objective on Option Care Health from $37.00 to $23.00 and set a “hold” rating for the company in a report on Friday, May 1st. Stephens set a $30.00 price objective on Option Care Health in a report on Friday, May 1st. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $26.00 price objective on shares of Option Care Health in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Option Care Health currently has an average rating of “Moderate Buy” and a consensus price target of $31.25.

Option Care Health Trading Down 3.3%

Shares of OPCH stock opened at $20.87 on Friday. The stock has a market capitalization of $3.28 billion, a PE ratio of 16.18, a P/E/G ratio of 1.16 and a beta of 0.68. Option Care Health, Inc. has a 1-year low of $18.01 and a 1-year high of $36.80. The business has a 50-day moving average of $25.13 and a 200 day moving average of $29.82. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.03. The company had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.Option Care Health’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, sell-side analysts anticipate that Option Care Health, Inc. will post 1.64 earnings per share for the current year.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.